The largest database of trusted experimental protocols

5 protocols using facscelesta flow cytometry

1

Neutralizing Antibody Evaluation for SARS-CoV-2 Entry

Check if the same lab product or an alternative is used in the 5 most similar protocols
96-well plates were seeded with 200 μl of ACE2/HEK293 cells (1.5×104 cells/ml). After a 24 h incubation, recombinant proteins or neutralizing antibody was added. Lentiviral particles capable of transducing 50% of the cells (CoV2-lenti, HKU1-lenti, and 229E-lenti) were added (~25 μl) 30 min later. Following a three-day culture, the ACE2/HEK293 cells were harvested and GFP expression levels determined by BD FACSCelesta flow cytometry. Each group contained 2–5 replicates.
+ Open protocol
+ Expand
2

Multicolor Flow Cytometry of Primary AML Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
0.5-1e6 freshly thawed primary AML cells were stained with our phenotyping panel containing antibodies against human CD45, CD34, CD117, CD11b, CD64 at 4°C for 15 mins, washed with ice cold FACS buffer, fix/perm for 20 mins using the BD Cytofix/Cytoperm kit (BD), washed with perm/wash, stained with intracellular antibody against human CD68 in perm/wash buffer for 30 mins, washed with FACS buffer, and resuspended in FACS buffer and analyzed on BD FACSCelesta flowcytometry (BD). FCS files were analyzed on Flowjo 10.5.3 (Flowjo).
+ Open protocol
+ Expand
3

Analyzing Multicellular Spheroid Response to Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multicellular spheroids were treated with RT, CTx or UniCAR T cell immunotherapy. Forty-eight hours after TM addition, spheroids were washed once with PBS + 2% FBS solution and were trypsinized at 37 °C for 5 min with shaking at 700 rpm. Then, cells were washed with PBS + 0.5% BSA solution, the final volume was adjusted to 100 μL and transferred to a 96-well plate. Six spheroids were used for each measurement. Live and dead cells were distinguished by adding 1 μg/mL of DAPI solution (Sigma-Aldrich, Taufkirchen, Germany). Data was acquired with BD FACS Celesta flow cytometry (BD Bioscience) or MACSQuant VYB Analyzer (Miltenyi Biotec GmbH). All flow cytometric analyses were carried out with FlowJo software (BD Biosciences, Ashland, OR, USA) or MACSQuantify Software (Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany). The percentage of Cal33 RR viable cells was determined using increasing CD98hc TM concentrations in the coculture assays to calculate the half-maximal effective concentration (EC50) using nonlinear regression fit in GraphPad Prism 9 [32 (link)].
+ Open protocol
+ Expand
4

Apoptosis and Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell apoptosis was analyzed by Annexin V-FITC and PI apoptosis-detection kits and Annexin V-PE and 7-amino-actinomycin D (7-AAD) apoptosis-detection kits (KeyGEN Biotech, Nanjing, Jiangsu, China). The cell cycle was analyzed by a PI cell cycle detection kit (KeyGEN Biotech, Nanjing, Jiangsu, China). For the silencing groups, MDA-MB-231 cells stably expressing FOXM1 shRNA and NC shRNA were treated with 4.0 μM Olaparib for 7 days. Cells were stained with Annexin V-PE and 7-AAD according to the manufacturer’s instructions to detect apoptosis. For the drug-treated groups, MDA-MB-231 cells and MDA-MB-468 cells were treated with different concentrations of FDI-6, Olaparib, or their combination for 7 days. After treatment, the cells were collected and stained with Annexin V-FITC and PI following the manufacturer’s protocol to analyze cell apoptosis. Cellular DNA was stained with PI following the manufacturer’s protocol. Cell apoptosis and the cell cycle were detected by BD FACSCelesta flow cytometry (New York, USA). Apoptosis data were analyzed by FlowJo 7.6, and the cell cycle data were analyzed by ModFit LT [31 (link)].
+ Open protocol
+ Expand
5

Neuronal Cell Isolation and Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trypsin (27252-018), collagenase II (QN0512), and DMEM (12800-017) were purchased from GIBCO. Fetal bovine serum (04-001-1ACS) was purchased from Biological Industries. Polylysine (P0296) was purchased from Sigma. DAPI (ab104139), anti-NeuN (ab177467), and Goat anti-rabbit IgG H&L (FITC, ab6717) were purchased from Abcam. BD Pharm Lyse lysing solution (No. 555899) was purchased from Becton Dickinson. The stationary liquid 0.01 M PBS solution) contained 3% formaldehyde and 20% sucrose. BD FACS Celesta Flow cytometry was obtained from BD Biosciences-US, and Cytation5 was obtained from BioTek.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!